Hepatitis C virus recombination protein and gene sequence
A hepatitis C virus and recombinant protein technology, applied in the field of genetic engineering, can solve the problems of false positive risk of rapid diagnosis products, missed detection of final diagnosis products, etc., to reduce the risk of missed detection, reduce the risk of false positives, and reduce the effect of small molecular weight
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0028] Example 1: Construction of recombinant vectors containing the hepatitis C virus core protein (core) gene
[0029] (1) Extraction of HCV virus
[0030] HCV RNA was extracted from human serum infected with HCV virus with a viral RNA extraction kit (Shanghai Sangon Bioengineering Service Co., Ltd., product number: SK1321).
[0031] (2) Recombinant vector construction of core protein gene
[0032]The upstream primer is (5'-3'): GCCCATATGAGCACGAATCCTAAACCT, with an NdeI restriction site, and the downstream primer is (5'-3'): CGCAAGCTTCCTACGCCGGGGGTCTG, with a HindIII restriction site, using the above primers to extract HCV RNA was used as a template, and the AMV RT-PCR kit (Shanghai Sangon Bioengineering Service Co., Ltd., article number: BS251) was used to prepare the HCV core region sequence according to the recommended conditions of the kit, and PCR (the polymerase of the present invention was a product of TOYOBO Company, Product number: 02510D1), PCR conditions are: 9...
Embodiment 2
[0033] Example 2: Screening monoclonal cells against hepatitis C virus core protein (core)
[0034] (1) Immunization: BALB / C mice, 6 weeks old, purchased from Shanghai Slack Experimental Animal Co., Ltd., each mouse was immunized with 50ug of core antigen, the first injection was emulsified with Freund’s complete adjuvant, the second, the third The first and fourth injections were emulsified with Freund's incomplete adjuvant, and the fifth injection was injected into the spleen, with an interval of 14 days between each injection.
[0035] (2) Fusion: 3 days after spleen injection, spleen cells were fused with mouse myeloma cells at a ratio of 5:1.
[0036] (3) Screening: positive cells were screened by ELISA method, and the positive cells were further cloned and screened until the monoclonal was stable. Specific method: use the core antigen 1ug / ml of the embodiment (1) and the embodiment (4), coat the microplate with 50ul per hole, seal the microplate with 1% BSA, take 50ul...
Embodiment 3
[0037] Example 3: Construction of single-chain antibodies against hepatitis C virus core protein (core)
[0038] (1) Extraction of cellular RNA
[0039] Total cellular RNA was extracted using TRIzol LS (product of Invitrogen, Cat. No. 10296-010) according to the instructions.
[0040] (2) Synthesis of the first strand of cDNA: Take 1 μg RNA as a template for reverse transcription, 1 μl of Oligo(d)T as a primer for reverse transcription, add DEPC water to a total volume of 12 μl, mix well; denature at 70°C for 5 minutes, and quickly cool in an ice bath; Add 4 μl of 5× buffer, 1 μl of RNase inhibitor, 2 μl of dNTP (10mM each), mix well; incubate at 37°C for 5 minutes; add 1 μl of AMV reverse transcriptase, reverse transcription at 37°C for 60 minutes; terminate the reaction at 70°C for 10 minutes; put on ice cool down.
[0041] (3) Using the reverse transcription cDNA as a template, use RT-PCR to amplify the heavy chain and light chain genes according to the following primer...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com